Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Menzin

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Psychiatric Services (Washington, D.C.)|April 30, 2003
Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid programJoseph Menzin, Luke Boulanger, Mark Friedman, et al.
Archives of Internal Medicine|July 19, 2002
The outcomes and costs of acute myeloid leukemia among the elderlyJoseph Menzin, Kathleen Lang, Craig C Earle, et al.
The Journal of Clinical Psychiatry|August 20, 2009
A model of the economic impact of a bipolar disorder screening program in primary careJoseph Menzin, Matthew Sussman, Eskinder Tafesse, et al.
Journal of Medical Economics|January 24, 2020
Cost-utility analyses of targeted immunomodulators in rheumatoid arthritis: systematic reviewMatthew Sussman, Charles Tao, Pankaj Patel, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 17, 2004
The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare dataKathleen Lang, Joseph Menzin, Craig C Earle, et al.
Managed Care Interface|February 6, 2007
Cost effectiveness of topiramate in the prevention of migraines in the United States: an updateJeffrey S Brown, Marcia F T Rupnow, Peter Neumann, et al.
Hospital Practice (1995)|December 16, 2014
Treatment patterns and outcomes among hospitalized patients with venous thromboembolism in the United States: an analysis of electronic health records dataJoseph Menzin, Ronald Preblick, Mark Friedman, et al.
Journal of Medical Economics|March 5, 2011
Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychoticsKathleen Lang, Jonathan Korn, Erik Muser, et al.
Cancer Medicine|April 6, 2019
Travel burden associated with rare cancers: The example of Merkel cell carcinomaRahul Jain, Joseph Menzin, Kristina Lachance, et al.
Managed Care Interface|August 9, 2006
The economic burden of intracerebral hemorrhage: evidence from managed careMason W Russell, Luke Boulanger, Ashish V Joshi, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Psychiatric Services (Washington, D.C.)|April 30, 2003
Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid programJoseph Menzin, Luke Boulanger, Mark Friedman, et al.
Archives of Internal Medicine|July 19, 2002
The outcomes and costs of acute myeloid leukemia among the elderlyJoseph Menzin, Kathleen Lang, Craig C Earle, et al.
The Journal of Clinical Psychiatry|August 20, 2009
A model of the economic impact of a bipolar disorder screening program in primary careJoseph Menzin, Matthew Sussman, Eskinder Tafesse, et al.
Journal of Medical Economics|January 24, 2020
Cost-utility analyses of targeted immunomodulators in rheumatoid arthritis: systematic reviewMatthew Sussman, Charles Tao, Pankaj Patel, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 17, 2004
The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare dataKathleen Lang, Joseph Menzin, Craig C Earle, et al.
Managed Care Interface|February 6, 2007
Cost effectiveness of topiramate in the prevention of migraines in the United States: an updateJeffrey S Brown, Marcia F T Rupnow, Peter Neumann, et al.
Hospital Practice (1995)|December 16, 2014
Treatment patterns and outcomes among hospitalized patients with venous thromboembolism in the United States: an analysis of electronic health records dataJoseph Menzin, Ronald Preblick, Mark Friedman, et al.
Journal of Medical Economics|March 5, 2011
Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychoticsKathleen Lang, Jonathan Korn, Erik Muser, et al.
Cancer Medicine|April 6, 2019
Travel burden associated with rare cancers: The example of Merkel cell carcinomaRahul Jain, Joseph Menzin, Kristina Lachance, et al.
Managed Care Interface|August 9, 2006
The economic burden of intracerebral hemorrhage: evidence from managed careMason W Russell, Luke Boulanger, Ashish V Joshi, et al.
Pageof 8